Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
CNY 35.71
(1.1%)
CNY 35.71
(1.1%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.85 Billion CNY | 19.14% |
| 2022 | 3.51 Billion CNY | 26.47% |
| 2021 | 2.8 Billion CNY | 7.82% |
| 2020 | 2.6 Billion CNY | -8.33% |
| 2019 | 2.76 Billion CNY | -0.38% |
| 2018 | 2.8 Billion CNY | 9.0% |
| 2017 | 2.48 Billion CNY | 50.8% |
| 2016 | 1.72 Billion CNY | 13.23% |
| 2015 | 1.6 Billion CNY | -20.93% |
| 2014 | 1.91 Billion CNY | 4.37% |
| 2013 | 1.77 Billion CNY | 20.39% |
| 2012 | 1.63 Billion CNY | 19.78% |
| 2011 | 1.37 Billion CNY | 47.49% |
| 2010 | 922.23 Million CNY | 45.07% |
| 2009 | 631.13 Million CNY | 36.43% |
| 2008 | 465.37 Million CNY | 37.63% |
| 2007 | 335.41 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.27 Billion CNY | -31.56% |
| 2024 Q1 | 1.71 Billion CNY | 41.1% |
| 2024 Q3 | 810.14 Million CNY | -31.78% |
| 2023 Q1 | 1.25 Billion CNY | 165.3% |
| 2023 Q4 | 1.19 Billion CNY | 49.0% |
| 2023 FY | - CNY | 19.14% |
| 2023 Q3 | 801.53 Million CNY | -10.73% |
| 2023 Q2 | 897.88 Million CNY | -28.72% |
| 2022 Q1 | 445.08 Million CNY | -0.6% |
| 2022 Q4 | 474.81 Million CNY | -40.72% |
| 2022 FY | - CNY | 26.47% |
| 2022 Q3 | 800.92 Million CNY | -12.5% |
| 2022 Q2 | 915.32 Million CNY | 105.65% |
| 2021 Q1 | 307.87 Million CNY | -40.15% |
| 2021 Q3 | 537.45 Million CNY | 7.45% |
| 2021 Q4 | 447.76 Million CNY | -16.69% |
| 2021 Q2 | 500.17 Million CNY | 62.46% |
| 2021 FY | - CNY | 7.82% |
| 2020 FY | - CNY | -8.33% |
| 2020 Q2 | 394.37 Million CNY | 102.94% |
| 2020 Q4 | 514.43 Million CNY | -3.88% |
| 2020 Q3 | 535.17 Million CNY | 35.7% |
| 2020 Q1 | 194.32 Million CNY | -46.37% |
| 2019 Q3 | 430.23 Million CNY | -31.67% |
| 2019 Q1 | 554.4 Million CNY | 46.59% |
| 2019 Q2 | 629.65 Million CNY | 13.57% |
| 2019 FY | - CNY | -0.38% |
| 2019 Q4 | 362.37 Million CNY | -15.77% |
| 2018 Q1 | 527.26 Million CNY | -41.61% |
| 2018 Q4 | 378.19 Million CNY | -16.43% |
| 2018 Q3 | 452.54 Million CNY | -36.61% |
| 2018 FY | - CNY | 9.0% |
| 2018 Q2 | 713.87 Million CNY | 35.39% |
| 2017 Q2 | 341.83 Million CNY | 1.44% |
| 2017 FY | - CNY | 50.8% |
| 2017 Q4 | 902.96 Million CNY | 134.07% |
| 2017 Q3 | 385.76 Million CNY | 12.85% |
| 2017 Q1 | 336.98 Million CNY | 6.82% |
| 2016 Q4 | 315.46 Million CNY | 22.71% |
| 2016 FY | - CNY | 13.23% |
| 2016 Q1 | 304.72 Million CNY | 46.88% |
| 2016 Q2 | 352.9 Million CNY | 15.81% |
| 2016 Q3 | 257.08 Million CNY | -27.15% |
| 2015 Q4 | 207.47 Million CNY | -18.21% |
| 2015 FY | - CNY | -20.93% |
| 2015 Q3 | 253.67 Million CNY | -27.29% |
| 2015 Q2 | 348.89 Million CNY | 14.81% |
| 2015 Q1 | 303.9 Million CNY | -38.29% |
| 2014 Q3 | 372.87 Million CNY | -20.26% |
| 2014 Q1 | 304.88 Million CNY | -48.87% |
| 2014 FY | - CNY | 4.37% |
| 2014 Q4 | 492.49 Million CNY | 32.08% |
| 2014 Q2 | 467.63 Million CNY | 53.38% |
| 2013 Q2 | 478.08 Million CNY | 83.91% |
| 2013 Q3 | 401.08 Million CNY | -16.11% |
| 2013 FY | - CNY | 20.39% |
| 2013 Q4 | 596.34 Million CNY | 48.68% |
| 2013 Q1 | 259.96 Million CNY | -51.97% |
| 2012 Q3 | 352.94 Million CNY | 5.17% |
| 2012 Q1 | 192.56 Million CNY | -53.08% |
| 2012 Q4 | 541.29 Million CNY | 53.37% |
| 2012 Q2 | 335.57 Million CNY | 74.27% |
| 2012 FY | - CNY | 19.78% |
| 2011 Q1 | 169.53 Million CNY | -46.47% |
| 2011 FY | - CNY | 47.49% |
| 2011 Q4 | 410.44 Million CNY | 29.43% |
| 2011 Q3 | 317.12 Million CNY | -8.74% |
| 2011 Q2 | 347.49 Million CNY | 104.96% |
| 2010 Q3 | 204.25 Million CNY | -5.05% |
| 2010 Q2 | 215.1 Million CNY | 80.57% |
| 2010 Q1 | 119.12 Million CNY | -31.04% |
| 2010 Q4 | 316.73 Million CNY | 55.07% |
| 2010 FY | - CNY | 45.07% |
| 2009 Q4 | 172.74 Million CNY | 8.62% |
| 2009 FY | - CNY | 36.43% |
| 2009 Q3 | 159.04 Million CNY | 12.43% |
| 2009 Q2 | 141.45 Million CNY | 57.43% |
| 2009 Q1 | 89.85 Million CNY | 0.0% |
| 2008 FY | - CNY | 37.63% |
| 2007 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 1.14 Billion CNY | -325.517% |
| Zhejiang Zhenyuan Share Co., Ltd. | 220.46 Million CNY | -2103.461% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | -83.34 Million CNY | 5928.699% |
| Hubei Guangji Pharmaceutical Co., Ltd. | -2.67 Million CNY | 181922.117% |
| Yifan Pharmaceutical Co., Ltd. | -483.52 Million CNY | 1104.662% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 66.15 Million CNY | -7243.527% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 116.49 Million CNY | -4069.988% |
| Boai NKY Medical Holdings Ltd. | 665.28 Million CNY | -630.177% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 391.09 Million CNY | -1142.104% |